Saturday 17 October 2026
Export OPRX’s income statement to Excel — free account
OptimizeRx Corp.
OPRX Healthcare Health Information Services
OptimizeRx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $109.4 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue fell 29.8%, EPS fell 150.0%, free cash flow grew 89.9% and total debt fell 33.1%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
8.50
0.35
−3.95%
Follow OPRX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.03% | 4.18% | 5.56% | 3.68% | |
Piotroski F-Score |
7 | 8 | 8 | 7 | |
| 0.02% | 2.95% | 4.08% | 2.76% | ||
ROIC |
3.24% | 5.60% | 6.68% | 5.41% | |
Return on Tangible Assets |
0.09% | 11.78% | 14.92% | 10.33% | |
Average Days of Receivables |
113.24 | 128.43 | 111.73 | 100.35 | |
Free Cash Flow per Share |
0.62 | 1.01 | 0.77 | 0.99 | |
Free Cash Flow |
11.57 | 18.78 | 14.52 | 18.57 | |
Capital Expenditures |
(0.26) | 0.07 | 0.13 | 0.14 | |
| Other line items | |||||
Cash ROIC |
6.81% | 10.59% | 8.38% | 10.66% | |
Accounts Receivable Turnover |
3.63 | 2.85 | 3.27 | 3.22 | |
Accounts Payable Turnover |
15.86 | 18.90 | 9.98 | 15.99 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
19.57 | 16.66 | 34.80 | 18.28 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.98) | (0.26) | (0.29) | (0.32) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 13.20% | |
Selling, General and Administrative Expense of Revenue |
49.35% | 52.28% | 52.33% | 57.12% | |
Share Based Compensation of Revenue |
7.25% | 6.36% | 6.74% | 8.06% | |
Interest Coverage |
1.21 | 2.21 | 2.75 | 2.33 | |
Operating CF/Net income |
358.33 | 3.65 | 2.10 | 4.01 | |
Depreciation/Fixed assets |
(17.42) | 51.29 | 52.25 | 44.43 | |
Capex/Depreciation |
0.12 | 0.01 | 0.02 | 0.03 | |
Revenue per Share |
5.90 | 5.90 | 5.72 | 5.25 | |
Operating CF per Share |
0.64 | 1.01 | 0.77 | 0.98 | |
Capex per Share |
(0.01) | 0.00 | 0.01 | 0.01 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates